Prof. Dr. Christoph R. MeierProfessor
Departement Pharmazeutische Wissenschaften
Prof. Christoph Meier graduated as pharmacist at the University of Basel in 1987. He got his PhD at the Division of Clinical Pharmacology at the University Hospital of Basel with Prof. F. Follath, and worked then for 4 years at the Division of Clinical Pharmacology at the University Hospital of Zürich with Prof. Peter Meier-Abt. Between 1995 and 1998 he conducted a postdoctoral fellowship at the Boston Collaborative Drug Surveillance Center (BCDSP) in Lexington, MA, USA, with Professor Hershel Jick and his daughter, Professor Susan Jick. He also got a Master degree in Epidemiology at the Harvard School of Public Health in Boston, MA, and an assistant professorship at the Boston University School of Public Health.
In 1998, Prof. Meier started to build up his own research unit at the Division of Clinical Pharmacology and Toxicology at the University Hospital of Basel (with Prof. S. Krähenbühl), the so-called "Basel Pharmacoepidemiology Unit". He has a close research collaboration with Prof. Susan Jick and colleagues at the Boston Collaborative Drug Surveillance Program in Lexington, MA. In 2008 he got a "Titularprofessorship" from the Faculty of Medicine at the University of Basel, and in 2009 he was elected head of the Hospital Pharmacy at the University Hospital and professor for Clinical Pharmacy and Pharmacoepidemiology at the Department of Pharmaceutical Sciences at the University of Basel, Switzerland. He serves as Department Head since 2012.
Member of the editor board of the journal Drug Safety, Member of the Human Medicines Expert Committee (HMEC) at Swissmedic
1995 – 1997 Postdoctoral fellowships from the Swiss National Science Foundation and from the Harvard University, Boston, MA 1999–2005 Research grants from the Swiss National Science Foundation entitled "Pharmacoepidemiologic Research Methods in Post-Marketing Surveillance of Drugs: Assessing Risks and Benefits of Long-Term Exposure to Drugs in Cardiovascular Medicine", and "Pharmacoepidemiologic Research Methods in Post-Marketing Surveillance of Drugs: Assessing Risks and Benefits of Long-Term Exposure to Drugs" 2002 Award "Best Doctoral Thesis of the Department of Internal Medicine at the University Hospital Basel in 2002" for my doctoral student Brigitta Schlegel, MD, who conducted a study entitled "HMG-CoA-reductase inhibitors and the risk of fractures", published in JAMA in 2000 2005 Clinical Award for the best publication of the year 2005 by the Swiss Bone and Mineral Society (SBMS) for the publication "Use of beta-blockers and the risk of bone fractures", published in JAMA 2004